Speaking to CNBC-TV18, Ravi Menon of Elara Capital outlined his investment picks from the sector.
In an interview with CNBC-TV18, NASSCOM President R Chandrashekhar and Sudin Apte of Offshore Insighs talked about the challenges faced the IT industry.
A number of large companies have posted results since the earnings season started Thursday last week.
With Infosys reporting first quarter results a day after sector leader TCS, a comparision between the two can now be made.
In an interview with CNBC-TV18's Rukmini Rao, Infosys CEO Vishal Sikka talked about the company's muted first quarter earnings and what he expects going forward.
The street is given a big thumbs down to the stock. Here are the 8 reasons that triggered selling.
Nilesh Shah, MD & CEO of Envision Capital maintained revised dollar guidance growth to be a major setback for the company. "The important variable (dollar revenue growth) of the result has fallen, and it is not a good sign for company, the sector and the entire earnings season," he added.
Sandip Agarwal, Edelweiss Financial Services thinks the constant currency growth of 3.1 percent will put pressure on TCS's Q2 and it will be hard for them to grow at 10 percent organically for the fiscal.
Overall, Q1 is expected to be a good quarter for the company. Dollar revenue growth is likely to be supported by currency tailwinds of 50-60 basis points, hence constant currency growth may be around 3.5 percent for the quarter.
Sales are expected to increase by 2.8 percent Q-o-Q (up 18.6 percent Y-o-Y) to Rs 17019.7 crore, according to Motilal Oswal
Revenues are expected to increase by 3.9 percent Q-o-Q (up 19.8 percent Y-o-Y) to Rs 17201.4 crore, according to Edelweiss Financial Services.
Sales are expected to increase by 3 percent Q-o-Q (up 18.8 percent Y-o-Y) to Rs 17052.1 crore, according to ICICIdirect.
In an interview with CNBC-TV18, Pankaj Pandey of ICICI Direct talked about the brokerage's expectations from the first quarter earnings season and outlined his view on various sectors.
The company operates amusement parks in Bengaluru, Hyderabad and Kochi and is looking to expand in 4-5 new markets in the next few years, Arun K Chittilappilly, Managing Director of Wonderla Holiday told CNBC-TV18.
Moshe Katri, MD of CRT Sterne Agee, believes Infosys has so far done an incredible job in reclaiming the lost market share and it must articulate on ways of transition of its legacy business into digital.
All three IT companies posted robust numbers, some were ahead of others when it comes to revenue, EBIT and profit growth.
In the largecap tech stocks, Urmil Shah, Research Analyst, Institutional Equities, IDBI Capital, prefers Infosys and HCL Tech and believes the former can reach valuations of 20 times by next year. Shah has a target price of Rs 1,381 on Infosys and believes it has higher upside compared to TCS.
The sterling results posted by IT major Infosys makes it a preferred pick over rival TCS, which is slated to post its own results later today, says Prabhudas Lilladher IT Analyst Govind Agarwal.
According to a CNBC-TV18 poll, TCS Q4 dollar revenue is expected to increase 1.4 percent at USD 4205 million compared to USD 4145 million on sequential basis. In rupee terms, revenue may grow 3.6 percent at Rs 28345 crore versus Rs 27364 crore quarter-on-quarter. Revenue is seen up 1.7-1.8 percent in constant currency.
The deal wins in Q4 helped growth and the aim is to touch USD 1 billion in deals in the next two to three quarters, says Vishal Sikka, MD & CEO of Infosys.
The company's employee strength has increased 10 percent in the year ended March 31,2016. Total number of employees at Infosys was 194044 in FY16. Number of trainees in Q4 was 6098.
Experts on CNBC-TV18 say that rupee depreciation helped margin growth for the IT bellwether. But watch out for recession in IT sector in another two-three quarters which might hit the company.
Sales of Infosys are expected to increase by 4.2 percent Q-o-Q (up 23.6 percent Y-o-Y) to Rs 16,575 crore, according to Motilal Oswal.
Headwinds from depreciation of the British pound (GBP) and other cross-currency movements may also negatively impact USD revenues by 30-50 basis points for the said quarter.
Speaking to CNBC-TV18, Gautam Chhaochharia said that he expects an earnings growth of around 10 percent for the fiscal year 2017 and sees a strong fourth quarter for the pharma sector on a year-on-year basis.